Vicarious Surgical (RBOTW) Long-Term Investments (2020 - 2021)
Vicarious Surgical (RBOTW) reported Long-Term Investments of $345.3 million for Q2 2021, little changed on a QoQ basis from $345.3 million in Q1 2021.
Vicarious Surgical (RBOTW) has 2 years of Long-Term Investments data on file, last reported at $345.3 million in Q2 2021.
- Quarterly Long-Term Investments changed N/A year-over-year to $345.3 million in Q2 2021, while the trailing twelve-month figure through Jun 2021 was $345.3 million (changed N/A YoY) and the FY2020 annual result came in at $345.2 million, changed N/A from the prior year.
- Long-Term Investments was little changed at $345.3 million in Q2 2021 per RBOTW's latest filing, from $345.3 million in the prior quarter.
- Across five years, Long-Term Investments topped out at $345.3 million in Q2 2021 and bottomed at $345.1 million in Q3 2020.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Long-Term Investments (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | 1.09 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | - |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | - |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | - |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | 285.60 Mn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 166.25 Mn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | - |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | - |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | - |
| 10 | Vicarious Surgical | - | - | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2021 | 345.27 Mn |
| Mar 31, 2021 | 345.26 Mn |
| Dec 31, 2020 | 345.19 Mn |
| Sep 30, 2020 | 345.09 Mn |